Principles and Metrics for Evaluating Oregon's Innovative Drug Decriminalization Measure
J Urban Health
.
2022 Apr;99(2):328-331.
doi: 10.1007/s11524-022-00606-w.
Epub 2022 Feb 2.
Authors
Jules Netherland
1
,
Alex H Kral
2
,
Danielle C Ompad
3
4
,
Corey S Davis
5
,
Ricky N Bluthenthal
6
,
Nabarun Dasgupta
7
,
Michael Gilbert
8
,
Riona Morgan
9
,
Haven Wheelock
8
Affiliations
1
Department of Research and Academic Engagement, Drug Policy Alliance, New York, NY, USA.
2
RTI International, Berkeley, CA, USA.
3
Department of Epidemiology, New York University School of Global Public Health, New York, NY, USA. danielle.ompad@nyu.edu.
4
Center for Drug Use and HIV|HCV Research, New York University School of Global Public Health, New York, NY, USA. danielle.ompad@nyu.edu.
5
Network for Public Health Law, Harm Reduction Legal Project, Los Angeles, CA, USA.
6
Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
7
Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
8
, Portland, OR, USA.
9
, New York, NY, USA.
PMID:
35107693
PMCID:
PMC8809225
DOI:
10.1007/s11524-022-00606-w
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Benchmarking*
Humans
Oregon
Grants and funding
P30 DA011041/DA/NIDA NIH HHS/United States